Crohn's Disease in
the Clinical Setting
About CIMZIA®
Dosing and
Administration
Clinical Trials Overview
Patient Support
Safety Information
Resources
For Patients & Caregivers
Prescribing Information


This site is intended for
US residents.

Patient FAQs

Your patients who are starting treatment with CIMZIA may have a lot of questions for you. That's why we developed the CIMZIA FAQs, which answer the most common questions patients have regarding CIMZIA. It also addresses how CIMZIA can help reduce the signs and symptoms of moderate to severe Crohn's disease in patients who have had an inadequate response to conventional therapy.

This guide is also available on the CIMZIA patient Web site, so you can direct patients to find it there. You may also find it helpful to read yourself in order to gain some insight into the kinds of concerns your patients may have about CIMZIA.

Simply download and print the guide by following the link below.

You can download the CIMZIA FAQs here.

You will need Adobe Acrobat Reader to view the form. You can download the latest version here.

CIMZIA is indicated for reducing signs and symptoms of Crohn's disease and maintaining clinical response in adult patients with moderately to severely active disease who have had an inadequate response to conventional therapy.
For more information 1.866.4.CIMZIA
CIMZIA